Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion
By Nikita Chaurasia  Date: 2020-09-14

Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion

NVIDIA, a leading American multinational technology firm, and SoftBank, a renowned Japanese conglomerate, have reportedly announced that NVIDIA would acquire Arm Limited from SoftBank Group for a total amount of $40 billion. The agreement would be immediately accretive to the gaming company’s non-GAAP earnings per share and non-GAAP gross margin.

The transaction would combine NVIDIA’s top AI computing platform and the vast ecosystem of Arm to develop the premier computing company for the era of AI (artificial intelligence), fostering innovation while expanding into high growth markets. Additionally, SoftBank would stay committed to Arm’s long-living success from NVIDIA’s ownership stake, which is expected to be less than 10 percent.

Arm CEO, Simon Segars stated that NVIDIA and Arm share a common passion and vision that energy-efficient and ubiquitous computing would help solve some prominent pressing problems ranging from healthcare to climate change, and education to agriculture.

Segars further added that working on such a vision need new approaches towards software, hardware as well as a long term commitment to R&D. The combination of two such companies can speed up the progress as well as develop solutions that would make a global ecosystem of innovators.

CEO and Founder of NVIDIA, Jensen Huang stated that AI is this era’s more powerful technology and it has induced a new computing wave. Over the coming years, about trillions of computers executing AI programs would develop a new internet-of-things which would be a several thousand times larger than the existing internet-of-people. The new combination would make a company that is in a good position for the coming AI age.

Huang further added that Arm’s CEO Simon Segars and the team have made Arm into an exceptional company that it is making contributions to almost every technology sector across the world. Merging the vast ecosystem of Arm with the AI computing capabilities of NVIDIA, would help the company can advance computing in PCs, robotics, self-driving cars, smartphones, cloud, edge IoT and further expand AI computing to every corner across the world.

Source credit: https://nvidianews.nvidia.com/news/nvidia-to-acquire-arm-for-40-billion-creating-worlds-premier-computing-company-for-the-age-of-ai

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...